New drugs propel Lilly profit beyond expectations
Charges from two acquisitions caused second-quarter profits at Eli Lilly and Co. to slip. Excluding those expenses and other adjustments, Lilly’s profit zoomed past Wall Street’s estimates. The Indianapolis-based drugmaker earned 90 cents per share, excluding unusual items. Analysts expected 82 cents per share, according to a survey by Thomson Financial. Lilly earned 76 cents […]